MedTrace Logo

Skip Prep of Vaginal Delivery to Prevent Puerperal / Perinatal Infection in Vaginal Delivery

NCT05122169 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4140

Last updated 2021-11-26

No results posted yet for this study

Summary

This is a multi-center, randomized, controlled trial study to find whether use of chlorhexidine-alcohol or povidone-iodine for pre-vaginal delivery skin prep is superior to reduce postpartum infection in pregnant women with vaginal delivery. The primary outcome is the episiotomy site infection.

Conditions

  • Vaginal Delivery
  • Surgical Site Infection

Interventions

DRUG

Povidone-Iodine

Skin preparation with povidone-iodine pre-vaginal delivery skin preparation.

DRUG

Chlorhexidine

Skin preparation with chlorhexidine-alcohol pre-vaginal delivery skin preparation.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-31
Primary Completion
2025-12-31
Completion
2026-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05122169 on ClinicalTrials.gov